Literature DB >> 33604786

Energetic Dissection of Mab-Specific Reversible Self-Association Reveals Unique Thermodynamic Signatures.

Mandi M Hopkins1,2, Arun Parupudi3, Jared S Bee3,4, David L Bain5.   

Abstract

PURPOSE: Reversible self-association (RSA) remains a challenge in the development of therapeutic monoclonal antibodies (mAbs). We recently analyzed the energetics of RSA for five IgG mAbs (designated as A-E) under matched conditions and using orthogonal methods. Here we examine the thermodynamics of RSA for two of the mAbs that showed the strongest evidence of RSA (mAbs C and E) to identify underlying mechanisms.
METHODS: Concentration-dependent dynamic light scattering and sedimentation velocity (SV) studies were carried out for each mAb over a range of temperatures. Because self-association was weak, the SV data were globally analyzed via direct boundary fitting to identify best-fit models, accurately determine interaction energetics, and account for the confounding effects of thermodynamic and hydrodynamic nonideality.
RESULTS: mAb C undergoes isodesmic self-association at all temperatures examined, with the energetics indicative of an enthalpically-driven reaction offset by a significant entropic penalty. By contrast, mAb E undergoes monomer-dimer self-association, with the reaction being entropically-driven and comprised of only a small enthalpic contribution.
CONCLUSIONS: Classical interpretations implicate van der Waals interactions and H-bond formation for mAb C RSA, and electrostatic interactions for mAb E. However, noting that RSA is likely coupled to additional equilibria, we also discuss the limitations of such interpretations.

Entities:  

Keywords:  analytical ultracentrifugation; dynamic light scattering; interacting systems; monoclonal antibody; nonideality; sedimentation velocity

Year:  2021        PMID: 33604786     DOI: 10.1007/s11095-021-02987-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

Review 1.  Challenges in the development of high protein concentration formulations.

Authors:  Steven J Shire; Zahra Shahrokh; Jun Liu
Journal:  J Pharm Sci       Date:  2004-06       Impact factor: 3.534

2.  Phase separation of an IgG1 antibody solution under a low ionic strength condition.

Authors:  Hirotaka Nishi; Makoto Miyajima; Hiroaki Nakagami; Masanori Noda; Susumu Uchiyama; Kiichi Fukui
Journal:  Pharm Res       Date:  2010-04-17       Impact factor: 4.200

3.  Technical Decision-Making with Higher Order Structure Data: Detecting Reversible Concentration-Dependent Self-Association in a Monoclonal Antibody and a Preliminary Investigation to Eliminate It.

Authors:  Julie Y Wei; George M Bou-Assaf; Damian Houde; Andrew Weiskopf
Journal:  J Pharm Sci       Date:  2015-08-26       Impact factor: 3.534

Review 4.  Mechanisms of protein aggregation.

Authors:  John S Philo; Tsutomu Arakawa
Journal:  Curr Pharm Biotechnol       Date:  2009-06       Impact factor: 2.837

5.  High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kinetics.

Authors:  John R Alford; Brent S Kendrick; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2008-08       Impact factor: 3.534

Review 6.  The therapeutic monoclonal antibody market.

Authors:  Dawn M Ecker; Susan Dana Jones; Howard L Levine
Journal:  MAbs       Date:  2015       Impact factor: 5.857

7.  Mechanism of reversible self-association of a monoclonal antibody: role of electrostatic and hydrophobic interactions.

Authors:  Reza Esfandiary; Arun Parupudi; Jose Casas-Finet; Dhanesh Gadre; Hasige Sathish
Journal:  J Pharm Sci       Date:  2014-11-18       Impact factor: 3.534

Review 8.  Accelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: review of methods and tools.

Authors:  Vladimir I Razinkov; Michael J Treuheit; Gerald W Becker
Journal:  J Biomol Screen       Date:  2015-01-09

9.  Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering.

Authors:  James C Geoghegan; Ryan Fleming; Melissa Damschroder; Steven M Bishop; Hasige A Sathish; Reza Esfandiary
Journal:  MAbs       Date:  2016-04-06       Impact factor: 5.857

10.  Determination of Interaction Parameters for Reversibly Self-Associating Antibodies: A Comparative Analysis.

Authors:  Mandi M Hopkins; Cherie L Lambert; Jared S Bee; Arun Parupudi; David L Bain
Journal:  J Pharm Sci       Date:  2018-03-20       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.